Moderna has withdrawn its application to approve the influenza-Covid-19 combination vaccine, intending to resubmit the application with additional data later
Miruna Brosban
Health
sursa foto: pexels.com
Always see our news on Google
The decision follows consultations with the FDA, which has requested new clinical trials for Covid-19 booster doses. Moderna shares fell 1.4% amid declining revenue from Covid-19 vaccines and concerns about the nomination of Robert F. Kennedy Jr. to be secretary of the Health Department. The FDA is expected to decide on the next-generation Covid-19 vaccine, part of the combination vaccine, with no anticipated delays.
Sources
Latest News
09:05
Taiwan is conducting large-scale military exercises to assess commanders' reactions to enemy movements.
08:43
Piedone has filed a criminal complaint with the DNA against the prefect of Timiș, Paul Finta. He accuses him of abuse of office in connection with the decision regarding the mayor of Timișoara, Dominic Fritz.
08:22
NASA: The upper stage of a SpaceX rocket will accidentally crash on the Moon on Wednesday, without posing a danger to Earth.
08:05
Gabriela Ruse, eliminated in the second round of the WTA 1000 tournament in Toronto by Anastasia Potapova
07:46
The Sector 6 City Hall will reduce lighting in parks and playgrounds to 50% to save energy.
See more news
NEWS ON THE SAME TOPICS
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
